title: Identification of selective inhibitors of VHSV from biased combinatorial libraries of N,N'-disubstituted 2,5-piperazinediones.
abstract: A combinatorial strategy has been used to design and identify inhibitors of viral haemorrhagic septicemia virus (VHSV), a salmonid rhabdovirus of economic importance. Two libraries of N,N'-disubstituted 2,5-piperazinediones (DKP), DKP-I and DKP-II were screened for inhibition of VHSV infectivity. Among the 98 DKP-derivatives (R1-DKP-R2) screened, a novel class of VHSV in vitro inhibitors was identified. Evidences are presented showing that the selected DKP-derivatives cause dose-dependent inhibition of VHSV infectivity in the absence of cellular toxicity. Preliminary characterization of its inhibition mechanism ruled out direct inactivation of the virus (virucidal effect) or interference with early viral replication steps. Furthermore, analysis of infection foci sizes, virus titers, viral protein accumulation and presence of cell free virus derived from VHSV-infected cell cultures in the presence of DKP-derivates suggested that virus assembly/release was impaired leading to a reduced virus spread in cell culture. New DKP-derivatives with a significant higher specific activity need to be developed to start testing its possible practical use but the selected DKP-derivatives described here may contribute to their further development as well as being tools to improve our knowledge on the fish rhabdovirus infection cycle.
authors.affiliation: IBMC, Miguel Hernández University, 03202 Elche, Spain.
authors.forename: V
authors.initials: V
authors.lastname: Mas
authors.forename: A
authors.initials: A
authors.lastname: Falco
authors.forename: I
authors.initials: I
authors.lastname: Brocal
authors.forename: L
authors.initials: L
authors.lastname: Perez
authors.forename: J M
authors.initials: JM
authors.lastname: Coll
authors.forename: A
authors.initials: A
authors.lastname: Estepa
mesh_terms: D000998:Antiviral Agents / Q000737:chemistry* / Q000302:isolation & purification / Q000494:pharmacology* / Q000633:toxicity; D020650:Combinatorial Chemistry Techniques; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D029141:Novirhabdovirus / Q000187:drug effects*; D010879:Piperazines / Q000737:chemistry* / Q000302:isolation & purification / Q000494:pharmacology* / Q000633:toxicity; D014764:Viral Proteins / Q000032:analysis; D019065:Virus Assembly / Q000187:drug effects
chemical_list: D000998:Antiviral Agents; D010879:Piperazines; D014764:Viral Proteins; C003905:3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione